Achieve Life Sciences, Inc. Research and Development Expense
Achieve Life Sciences, Inc. (ACHV) reported Research and Development Expense of $5.32 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-11-06
- Achieve Life Sciences, Inc. research and development expense for the quarter ending 2025-09-30 was $5.32M, a 30.08% decline year-over-year.
- Achieve Life Sciences, Inc. research and development expense for the quarter ending 2025-06-30 was $6.71M, a 31.18% increase year-over-year.
- Achieve Life Sciences, Inc. research and development expense for the quarter ending 2025-03-31 was $7.10M, a 153.55% increase year-over-year.
- Achieve Life Sciences, Inc. research and development expense for the quarter ending 2024-12-31 was $7.30M, a 245.13% increase year-over-year.
- Achieve Life Sciences, Inc. research and development expense for fiscal 2024 was $22.82M, a 44.28% increase from fiscal 2023.
- Achieve Life Sciences, Inc. research and development expense for fiscal 2023 was $15.81M, a 47.42% decline from fiscal 2022.
- Achieve Life Sciences, Inc. research and development expense for fiscal 2022 was $30.08M, a 25.50% increase from fiscal 2021.
- Achieve Life Sciences, Inc. research and development expense for fiscal 2021 was $23.97M, a 248.24% increase from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $5.32M 10-Q · filed 2025-11-06 | $12.03M derived: sum of 2 quarters · filed 2025-11-06 | $19.12M 10-Q · filed 2025-11-06 | $26.42M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2025-06-30 | $6.71M 10-Q · filed 2025-08-07 | $13.80M 10-Q · filed 2025-08-07 | $21.10M derived: sum of 3 quarters · filed 2025-08-07 | $28.71M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2025-03-31 | $7.10M 10-Q · filed 2025-05-13 | $14.39M derived: sum of 2 quarters · filed 2025-05-13 | $22.00M derived: sum of 3 quarters · filed 2025-11-06 | $27.11M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $14.90M derived: sum of 2 quarters · filed 2025-11-06 | $20.02M derived: sum of 3 quarters · filed 2025-11-06 | $22.82M 10-K · filed 2025-03-11 | |||||
| 2024-09-30 | $7.61M 10-Q · filed 2025-11-06 | $12.72M derived: sum of 2 quarters · filed 2025-11-06 | $15.52M 10-Q · filed 2025-11-06 | $17.64M derived: sum of 4 quarters · filed 2025-11-06 | |||||
| 2024-06-30 | $5.11M 10-Q · filed 2025-08-07 | $7.91M 10-Q · filed 2025-08-07 | $10.03M derived: sum of 3 quarters · filed 2025-08-07 | $13.61M derived: sum of 4 quarters · filed 2025-08-07 | |||||
| 2024-03-31 | $2.80M 10-Q · filed 2025-05-13 | $4.91M derived: sum of 2 quarters · filed 2025-05-13 | $8.49M derived: sum of 3 quarters · filed 2025-05-13 | $13.08M derived: sum of 4 quarters · filed 2025-05-13 | |||||
| 2023-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $5.70M derived: sum of 2 quarters · filed 2025-03-11 | $10.28M derived: sum of 3 quarters · filed 2025-03-11 | $15.81M 10-K · filed 2025-03-11 | |||||
| 2023-09-30 | $3.58M 10-Q · filed 2024-11-07 | $8.17M derived: sum of 2 quarters · filed 2024-11-07 | $13.70M 10-Q · filed 2024-11-07 | $22.31M derived: sum of 4 quarters · filed 2025-03-11 | |||||
| 2023-06-30 | $4.58M 10-Q · filed 2024-08-13 | $10.12M 10-Q · filed 2024-08-13 | $18.73M derived: sum of 3 quarters · filed 2025-03-11 | $28.60M derived: sum of 4 quarters · filed 2025-03-11 | |||||
| 2023-03-31 | $5.53M 10-Q · filed 2024-05-09 | $14.15M derived: sum of 2 quarters · filed 2025-03-11 | $24.02M derived: sum of 3 quarters · filed 2025-03-11 | $31.22M derived: sum of 4 quarters · filed 2025-03-11 | |||||
| 2022-12-31 | $8.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $18.48M derived: sum of 2 quarters · filed 2025-03-11 | $25.69M derived: sum of 3 quarters · filed 2025-03-11 | $30.08M 10-K · filed 2025-03-11 | |||||
| 2022-09-30 | $9.87M 10-Q · filed 2023-11-09 | $17.08M derived: sum of 2 quarters · filed 2023-11-09 | $21.46M 10-Q · filed 2023-11-09 | $25.97M derived: sum of 4 quarters · filed 2023-11-09 | |||||
| 2022-06-30 | $7.21M 10-Q · filed 2023-08-14 | $11.60M 10-Q · filed 2023-08-14 | $16.10M derived: sum of 3 quarters · filed 2023-08-14 | $20.69M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $4.39M 10-Q · filed 2023-05-09 | $8.89M derived: sum of 2 quarters · filed 2023-05-09 | $13.48M derived: sum of 3 quarters · filed 2023-05-09 | $22.71M derived: sum of 4 quarters · filed 2023-05-09 | |||||
| 2021-12-31 | $4.51M 10-K · filed 2022-03-10 | $9.10M derived: sum of 2 quarters · filed 2022-11-14 | $18.32M derived: sum of 3 quarters · filed 2022-11-14 | $23.97M 10-K · filed 2024-03-28 | |||||
| 2021-09-30 | $4.59M 10-Q · filed 2022-11-14 | $13.82M derived: sum of 2 quarters · filed 2022-11-14 | $19.46M 10-Q · filed 2022-11-14 | $21.81M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $9.23M 10-Q · filed 2022-08-11 | $14.87M 10-Q · filed 2022-08-11 | $17.22M derived: sum of 3 quarters · filed 2022-08-11 | $19.11M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $5.64M 10-Q · filed 2022-05-12 | $7.99M derived: sum of 2 quarters · filed 2022-05-12 | $9.88M derived: sum of 3 quarters · filed 2022-05-12 | $10.98M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $2.35M 10-K · filed 2022-03-10 | $4.24M derived: sum of 2 quarters · filed 2022-03-10 | $5.34M derived: sum of 3 quarters · filed 2022-03-10 | $6.88M 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | $1.89M 10-K · filed 2022-03-10 | $2.99M derived: sum of 2 quarters · filed 2022-03-10 | $4.54M 10-Q · filed 2021-11-09 | $6.30M derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2020-06-30 | $1.10M 10-K · filed 2022-03-10 | $2.64M 10-Q · filed 2021-08-12 | $4.41M derived: sum of 3 quarters · filed 2022-03-10 | $6.23M derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2020-03-31 | $1.54M 10-K · filed 2022-03-10 | $3.30M derived: sum of 2 quarters · filed 2022-03-10 | $5.13M derived: sum of 3 quarters · filed 2022-03-10 | $7.16M derived: sum of 4 quarters · filed 2022-03-10 | |||||
| 2019-12-31 | $1.76M 10-K · filed 2021-03-11 | $3.59M derived: sum of 2 quarters · filed 2021-03-11 | $5.62M derived: sum of 3 quarters · filed 2021-03-11 | $9.67M 10-K · filed 2022-03-10 | |||||
| 2019-09-30 | $1.82M 10-K · filed 2021-03-11 | $3.86M derived: sum of 2 quarters · filed 2021-03-11 | $7.91M 10-Q · filed 2020-11-12 | $9.99M derived: sum of 4 quarters · filed 2021-03-11 | |||||
| 2019-06-30 | $2.03M 10-K · filed 2021-03-11 | $6.09M 10-Q · filed 2020-08-06 | $8.17M derived: sum of 3 quarters · filed 2021-03-11 | $9.71M derived: sum of 4 quarters · filed 2021-03-11 | |||||
| 2019-03-31 | $4.05M 10-K · filed 2021-03-11 | $6.14M derived: sum of 2 quarters · filed 2021-03-11 | $7.68M derived: sum of 3 quarters · filed 2021-03-11 | $8.72M derived: sum of 4 quarters · filed 2021-03-11 | |||||
| 2018-12-31 | $2.08M 10-K · filed 2020-03-13 | $3.62M derived: sum of 2 quarters · filed 2020-03-13 | $4.67M derived: sum of 3 quarters · filed 2020-03-13 | $5.87M 10-K · filed 2021-03-11 | |||||
| 2018-09-30 | $1.54M 10-K · filed 2020-03-13 | $2.59M derived: sum of 2 quarters · filed 2020-03-13 | $3.79M 10-Q · filed 2019-11-06 | $5.94M derived: sum of 4 quarters · filed 2020-03-13 | |||||
| 2018-06-30 | $1.04M 10-K · filed 2020-03-13 | $2.25M 10-Q · filed 2019-08-08 | $4.40M derived: sum of 3 quarters · filed 2020-03-13 | $5.22M derived: sum of 4 quarters · filed 2020-03-13 | |||||
| 2018-03-31 | $1.20M 10-K · filed 2020-03-13 | $3.35M derived: sum of 2 quarters · filed 2020-03-13 | $4.18M derived: sum of 3 quarters · filed 2020-03-13 | $4.24M derived: sum of 4 quarters · filed 2020-03-13 | |||||
| 2017-12-31 | $2.15M 10-K · filed 2019-03-14 | $2.98M derived: sum of 2 quarters · filed 2019-03-14 | $3.04M derived: sum of 3 quarters · filed 2019-03-14 | $3.10M 10-K · filed 2020-03-13 | |||||
| 2017-09-30 | $825.00K 10-K · filed 2019-03-14 | $887.00K derived: sum of 2 quarters · filed 2019-03-14 | $948.00K 10-Q · filed 2018-11-07 | $1.03M derived: sum of 4 quarters · filed 2019-03-14 | |||||
| 2017-06-30 | $62.00K 10-K · filed 2019-03-14 | $777.00K 10-Q · filed 2017-07-31 | $123.00K 10-Q · filed 2018-08-08 | $1.69M 10-Q · filed 2017-07-31 | $203.00K derived: sum of 3 quarters · filed 2019-03-14 | $272.00K derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-03-31 | $61.00K 10-K · filed 2019-03-14 | $912.00K 10-Q · filed 2017-05-15 | $141.00K derived: sum of 2 quarters · filed 2019-03-14 | $210.00K derived: sum of 3 quarters · filed 2019-03-14 | $282.00K derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2016-12-31 | $80.00K 10-K · filed 2018-03-01 | $1.70M 10-K · filed 2017-02-23 | $149.00K derived: sum of 2 quarters · filed 2018-03-01 | $221.00K derived: sum of 3 quarters · filed 2018-03-01 | $286.00K 10-K · filed 2019-03-14 | $14.79M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $69.00K 10-K · filed 2018-03-01 | $3.78M 10-Q · filed 2016-11-10 | $141.00K derived: sum of 2 quarters · filed 2018-03-01 | $206.00K 10-Q · filed 2017-11-09 | $13.09M 10-Q · filed 2016-11-10 | $6.79M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $72.00K 10-K · filed 2018-03-01 | $4.66M 10-Q · filed 2016-08-04 | $9.30M 10-Q · filed 2017-07-31 | $6.72M derived: sum of 3 quarters · filed 2018-03-01 | $15.03M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $65.00K 10-K · filed 2018-03-01 | $4.64M 10-Q · filed 2016-05-12 | $6.65M derived: sum of 2 quarters · filed 2018-03-01 | $14.96M derived: sum of 3 quarters · filed 2018-03-01 | $21.50M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $6.59M 10-K · filed 2017-02-23 | $14.89M derived: sum of 2 quarters · filed 2017-02-23 | $107.00K 10-K · filed 2018-03-01 | $21.43M derived: sum of 3 quarters · filed 2017-02-23 | $25.11M 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | $8.30M 10-K · filed 2017-02-23 | $14.85M derived: sum of 2 quarters · filed 2017-02-23 | $18.52M 10-Q · filed 2016-11-10 | $28.37M derived: sum of 4 quarters · filed 2017-02-23 | |||||
| 2015-06-30 | $6.54M 10-K · filed 2017-02-23 | $10.22M 10-Q · filed 2016-08-04 | $20.07M derived: sum of 3 quarters · filed 2017-02-23 | $29.66M derived: sum of 4 quarters · filed 2017-02-23 | |||||
| 2015-03-31 | $3.67M 10-K · filed 2017-02-23 | $13.53M derived: sum of 2 quarters · filed 2017-02-23 | $23.11M derived: sum of 3 quarters · filed 2017-02-23 | $32.99M derived: sum of 4 quarters · filed 2017-02-23 | |||||
| 2014-12-31 | $9.85M 10-K · filed 2016-03-09 | $19.44M derived: sum of 2 quarters · filed 2016-03-09 | $29.32M derived: sum of 3 quarters · filed 2016-03-09 | $46.22M 10-K · filed 2017-02-23 | |||||
| 2014-09-30 | $9.59M 10-Q · filed 2014-10-30 | $19.47M derived: sum of 2 quarters · filed 2016-03-09 | $36.37M 10-Q · filed 2015-11-12 | $49.57M derived: sum of 4 quarters · filed 2016-03-09 | |||||
| 2014-06-30 | $9.88M 10-K · filed 2016-03-09 | $26.79M 10-Q · filed 2015-08-13 | $39.98M derived: sum of 3 quarters · filed 2016-03-09 | $57.98M derived: sum of 4 quarters · filed 2016-03-09 | |||||
| 2014-03-31 | $16.90M 10-K · filed 2016-03-09 | $30.10M derived: sum of 2 quarters · filed 2016-03-09 | $48.10M derived: sum of 3 quarters · filed 2016-03-09 | $61.37M derived: sum of 4 quarters · filed 2016-03-09 | |||||
| 2013-12-31 | $13.20M 10-K · filed 2015-03-26 | $31.20M derived: sum of 2 quarters · filed 2015-03-26 | $44.46M derived: sum of 3 quarters · filed 2015-03-26 | $55.32M 10-K · filed 2016-03-09 | |||||
| 2013-09-30 | $18.00M 10-K · filed 2015-03-26 | $31.27M derived: sum of 2 quarters · filed 2015-03-26 | $42.12M 10-Q · filed 2014-10-30 | $57.77M derived: sum of 4 quarters · filed 2015-03-26 | |||||
| 2013-06-30 | $13.26M 10-K · filed 2015-03-26 | $24.12M 10-Q · filed 2014-08-07 | $39.76M derived: sum of 3 quarters · filed 2015-03-26 | $52.66M derived: sum of 4 quarters · filed 2015-03-26 | |||||
| 2013-03-31 | $10.86M 10-K · filed 2015-03-26 | $26.50M derived: sum of 2 quarters · filed 2015-03-26 | $39.40M derived: sum of 3 quarters · filed 2015-03-26 | $45.72M derived: sum of 4 quarters · filed 2015-03-26 | |||||
| 2012-12-31 | $15.64M 10-K · filed 2014-03-11 | $28.54M derived: sum of 2 quarters · filed 2014-03-11 | $34.87M derived: sum of 3 quarters · filed 2014-03-11 | $39.95M 10-K · filed 2015-03-26 | |||||
| 2012-09-30 | $12.89M 10-K · filed 2014-03-11 | $19.22M derived: sum of 2 quarters · filed 2014-03-11 | $24.30M 10-Q · filed 2013-11-07 | $31.78M derived: sum of 4 quarters · filed 2014-03-11 | |||||
| 2012-06-30 | $6.33M 10-K · filed 2014-03-11 | $11.41M 10-Q · filed 2013-08-08 | $18.89M derived: sum of 3 quarters · filed 2014-03-11 | $22.70M derived: sum of 4 quarters · filed 2014-03-11 | |||||
| 2012-03-31 | $5.08M 10-K · filed 2014-03-11 | $12.56M derived: sum of 2 quarters · filed 2014-03-11 | $16.37M derived: sum of 3 quarters · filed 2014-03-11 | $21.78M derived: sum of 4 quarters · filed 2014-03-11 | |||||
| 2011-12-31 | $7.48M 10-K · filed 2013-03-07 | $11.29M derived: sum of 2 quarters · filed 2013-03-07 | $16.70M derived: sum of 3 quarters · filed 2013-03-07 | $21.55M 10-K · filed 2014-03-11 | |||||
| 2011-09-30 | $3.81M 10-K · filed 2013-03-07 | $9.22M derived: sum of 2 quarters · filed 2013-03-07 | $14.08M 10-Q · filed 2012-11-08 | $16.38M derived: sum of 4 quarters · filed 2013-03-07 | |||||
| 2011-06-30 | $5.41M 10-K · filed 2013-03-07 | $10.26M 10-Q · filed 2012-08-02 | $12.56M derived: sum of 3 quarters · filed 2013-03-07 | $19.29M derived: sum of 4 quarters · filed 2013-03-07 | |||||
| 2011-03-31 | $4.85M 10-K · filed 2013-03-07 | $7.15M derived: sum of 2 quarters · filed 2013-03-07 | $13.88M derived: sum of 3 quarters · filed 2013-03-07 | $16.96M derived: sum of 4 quarters · filed 2013-03-07 | |||||
| 2010-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $9.02M derived: sum of 2 quarters · filed 2013-03-07 | $12.10M derived: sum of 3 quarters · filed 2013-03-07 | $18.48M 10-K · filed 2013-03-07 | |||||
| 2010-09-30 | $6.72M 10-Q · filed 2011-11-03 | $9.80M derived: sum of 2 quarters · filed 2011-11-03 | $16.18M 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | $3.08M 10-Q · filed 2011-08-05 | $9.46M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $20.21M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |